This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Vowst (fecal microbiota spores, live-brpk; formerly SER-109) for prevention of recurrent Clostridioides difficile infection (rCDI).
Evidence Analysis
It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
- Does the technology improve health outcomes?
- Are there other benefits associated with the technology?
- What harms might be associated with the technology?
- Have patient selection criteria been established for the technology?
- For which patients might the technology provide a benefit?
- Health Technology Assessments
- Evidence Analysis Research Briefs
- Evolving Evidence Review
- Clinical Research Responses
Rebyota (Fecal Microbiota, Live-jslm) for Prevention of Recurrent Clostridioides Difficile Infection
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Rebyota (fecal microbiota, live-jslm) for prevention of recurrent Clostridioides difficile infection (rCDI).
ApiFix (ApiFix Ltd.) for Treatment of Adolescent Idiopathic Scoliosis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the currently available design of the ApiFix (ApiFix Ltd.) minimally invasive deformity correction system for spinal curvature correction in the treatment of adolescent idiopathic scoliosis.
Kerecis Omega3 Wound (Kerecis) Fish Skin Grafts for the Management of Diabetic Foot Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound fish skin grafts for improving healing and closure of diabetic foot ulcers (DFUs).
Kerecis Omega3 Wound (Kerecis) Fish Skin Grafts for Management of Burns
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound (Kerecis) fish skin grafts for treatment of burns.
Platelet-Rich Plasma for Treatment of Patellar Tendinopathy
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma for treatment of patellar tendinopathy.
inFlow Intraurethral Valve-Pump and Activator (Vesiflo Inc.) for Bladder Drainage in Female Patients with Chronic Urinary Retention
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the inFlow Intraurethral Valve-Pump and Activator (Vesiflo Inc.) for bladder drainage in female patients with chronic urinary retention.
NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for Treatment of Diabetic Foot Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for treatment of diabetic foot ulcers (DFUs).
EyeBOX (Oculogica) as an Aid in Diagnosis of Concussion
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the EyeBOX test (Oculogica) as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mild TBI).
Vivistim Paired VNS System (MicroTransponder Inc.) for Treatment of Upper Limb Impairment Due to Stroke
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Vivistim Paired Vagus Nerve Stimulation (VNS) System (MicroTransponder Inc.) for rehabilitation of upper extremity impairment following stroke.